Australia markets close in 1 hour 3 minutes

    +71.70 (+0.98%)
  • ASX 200

    +69.00 (+0.97%)

    +0.0001 (+0.02%)
  • OIL

    +0.39 (+0.60%)
  • GOLD

    +3.00 (+0.16%)

    +964.74 (+1.29%)
  • CMC Crypto 200

    +139.70 (+9.73%)

    +0.0006 (+0.09%)

    +0.0010 (+0.09%)
  • NZX 50

    -95.20 (-0.75%)

    +105.93 (+0.78%)
  • FTSE

    +53.54 (+0.76%)
  • Dow Jones

    +229.26 (+0.66%)
  • DAX

    +202.95 (+1.34%)
  • Hang Seng

    -93.17 (-0.33%)
  • NIKKEI 225

    +160.26 (+0.55%)

LAMEA Electronic Clinical Outcome Assessment Market Report 2021 -

·3-min read

The "LAMEA Electronic Clinical Outcome Assessment Market By Delivery Mode, By End Use, By Country, Industry Analysis and Forecast, 2020 - 2026" report has been added to's offering.

The Latin America, Middle East and Africa Electronic Clinical Outcome Assessment Solution Market (ECOA) is expected to witness market growth of 20.2% CAGR during the forecast period (2020-2026).

The Web-hosted eCOA market dominated the South Africa Electronic Clinical Outcome Assessment (eCOA) Solutions Market by Delivery Mode in 2019, thereby, achieving a market value of $16.6 Million by 2026. The Cloud-based eCOA market is showcasing a CAGR of 21.6% during (2020 - 2026).

A Patient's mental state, the prognosis of a disease, illness conditions, and the role of a patient in that situation can be evaluated with the help of Electronic clinical outcome assessment (eCOAs). The process of medical assessment can help in deciding if a drug is prescribed for the treatment or not. Some parts of electronic clinical outcome assessment are Clinician Reported Outcome Assessment (CLINRO), Observer Reported Outcome Assessment (OBSRO), Performance Outcome Assessment (PERFO), and Patient Reported Outcome Assessment (PRO).

There are various healthcare facilities such as health centers, hospitals, and clinical research organizations (CROs) groups that cover health issues. The increasing number of initiatives regarding the deployment of eClinical solutions taken by several private-public bodies & the rising adoption of eCOA among clinical research professionals are some of the primary factors that is expected to fuel the growth of the global eCOA market.

The growth of the eCOA market is anticipated to be propelled by the increasing awareness of the electronic clinical outcome assessment (eCOA) & the effectiveness of these solutions. Leading players can obtain a competitive edge with the help of several research studies that aim to create advanced & new electronic clinical outcome assessment (eCOA); thereby creating various growth avenues for the electronic clinical outcome assessment (eCOA) market.

On the other hand, the major restraints for the market growth are the absence of an appropriate healthcare IT framework & difficult regulatory approvals for these solutions in emerging countries.

Scope of the Study

Market Segments covered in the Report:

By Delivery Mode

  • Web-hosted eCOA

  • Cloud-based eCOA

  • Licensed enterprises eCOA

By End Use

  • Contract Research Organizations (CROs)

  • Hospitals

  • Academic Institutes

  • Pharma & Biotech Companies

  • Medical Device Manufacturers

By Country

  • Brazil

  • Argentina

  • UAE

  • Saudi Arabia

  • South Africa

  • Nigeria

  • Rest of LAMEA

Companies Profiled

  • Oracle Corporation

  • Dassault Systemes SE

  • IQVIA Holdings, Inc.

  • Parexel International Corporation (Pamplona Capital Management)

  • IBM Corporation (Merge Healthcare)

  • Signant Health

  • ERT Clinical

  • eClinical Solutions LLC

  • Castor EDC

  • Anju Software, Inc. (OmniComm Systems)

For more information about this report visit

View source version on

Laura Wood, Senior Press Manager

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900